Skip to main content
Erschienen in: Critical Care 1/2019

Open Access 01.12.2019 | Research

Ultrasound-based clinical profiles for predicting the risk of intradialytic hypotension in critically ill patients on intermittent dialysis: a prospective observational study

verfasst von: Rogerio da Hora Passos, Juliana Caldas, Joao Gabriel Rosa Ramos, Erica Batista dos Santos Galvão de Melo, Michel Por Deus Ribeiro, Maria Fernanda Coelho Alves, Paulo Benigno Pena Batista, Octavio Henrique Coelho Messeder, Augusto Manoel de Carvalho de Farias, Etienne Macedo, Jean Jacques Rouby

Erschienen in: Critical Care | Ausgabe 1/2019

Abstract

Background

Intradialytic hypotension, a complication of intermittent hemodialysis, decreases the efficacy of dialysis and increases long-term mortality. This study was aimed to determine whether different predialysis ultrasound cardiopulmonary profiles could predict intradialytic hypotension.

Methods

This prospective observational single-center study was performed in 248 critically ill patients with acute kidney injury undergoing intermittent hemodialysis. Immediately before hemodialysis, vena cava collapsibility was measured by vena cava ultrasound and pulmonary congestion by lung ultrasound. Factors predicting intradialytic hypotension were identified by multiple logistic regression analysis.

Results

Intradialytic hypotension was observed in 31.9% (n = 79) of the patients, interruption of dialysis because of intradialytic hypotension occurred in 6.8% (n = 31) of the sessions, and overall 28-day mortality was 20.1% (n = 50). Patients were classified in four ultrasound profiles: (A) 108 with B lines > 14 and vena cava collapsibility > 11.5 mm m−2, (B) 38 with B lines < 14 and vena cava collapsibility ≤ 11.5 mm m−2, (C) 36 with B lines > 14 and vena cava collapsibility Di ≤ 11.5 mm m−2, and (D) 66 with B lines < 14 and vena cava collapsibility > 11.5 mm m−2. There was an increased risk of intradialytic hypotension in patients receiving norepinephrine (odds ratios = 15, p = 0.001) and with profiles B (odds ratios = 12, p = 0.001) and C (odds ratios = 17, p = 0.001).

Conclusion

In critically ill patients on intermittent hemodialysis, the absence of hypervolemia as assessed by lung and vena cava ultrasound predisposes to intradialytic hypotension and suggests alternative techniques of hemodialysis to provide better hemodynamic stability.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s13054-019-2668-2.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
IDH
Intradialytic hypotension
ICU
Intensive care unit
AKI
Acute kidney injury
MAP
Mean arterial pressure
IVC
Inferior vena cava
IVCmax
Maximal IVC diameter
IVCmin
Minimum IVC diameter
IVCCI
IVC collapsibility index
IQR
Interquartile range
CRRT
Continuous renal replacement therapies

Introduction

Ultrafiltration-induced fluid removal for fluid balance control is a major target of renal replacement therapy [1]. However, in critically ill patients, intradialytic hypotension (IDH) is a frequent complication of intermittent hemodialysis and it may decrease the efficacy of renal replacement therapy [2, 3].
The ultrafiltration rate is set to ensure fluid removal required to reduce fluid overload. However, assessment of fluid overload in critically ill patients may be a challenge, because pulmonary congestion is poorly correlated with clinical signs [4]. One alternative approach is the utilization of transthoracic lung ultrasound. A score based on the number of B lines accurately measures the degree of lung congestion and may guide ultrafiltration rate [46]. In addition, the rate of disappearance of B lines during intermittent hemodialysis shows a good correlation with the volume of ultrafiltration and dry weight [7, 8].
The pathogenesis of IDH includes the dialysis process itself and critically ill patient-related factors. It has been postulated that the ultrafiltration rate may lead to a reduction in preload, predisposing to hemodynamic instability. Moreover, the dialysis process may interfere with compensatory mechanisms, predisposing to an increased risk of hypotension [9]. As such, it is not clear whether IDH is directly related to preload dependence or to other factors. Clinical studies have been controversial. One study has reported that a positive passive leg raising test before starting dialysis predicts IDH during renal replacement therapy [10]. Another has shown that, in critically ill patients, the majority of hypotensive episodes occurring during intermittent hemodialysis are unrelated to preload dependence and likely related to vasomotor tone alterations [11]. Furthermore, clinical and radiological tools for assessing volume status are subjected to a wide variability of interpretation [12, 13]. As an alternative, the ultrasound measurement of inferior vena cava diameter has been reported to be an accurate method for the assessment of fluid status in critically ill patients [14] and in patients undergoing hemodialysis [1517].
Although several studies have confirmed the emergent role of biomarkers such as natriuretic peptides [18], copeptin, and bioimpedance vector analysis (BIVA) in the management of volume overload, bedside lung ultrasound appears a sensitive tool for evaluating changes in extravascular lung water in dialysis patients [18, 19]. The primary aim of the present study is to determine whether different predialytic cardiopulmonary profiles, defined on sonographic findings, could predict IDH in critically ill patients undergoing intermittent hemodialysis. The secondary aim was to identify risk factors for IDH in this population.

Methods

Study design

This was a prospective observational single-center study performed between January 1, 2015, and April 30, 2018, in a 30-bed medical intensive care unit (ICU), at Hospital Português, a tertiary hospital in Salvador, Brazil. The study was approved by the Ethical Committee from Centro de Estudos Egaz Muniz (CAAE: 89428318.000005029). Written informed consent was waived for this observational and non-interventional study. Critically ill patients were included in the study if they fulfilled the following criteria: (i) age > 18 years, (ii) acute kidney injury (AKI) defined by KDIGO 3, and (iii) treatment by intermittent hemodialysis. Patients with right ventricle dysfunction, valvar heart disease, lung hyperinflation, increased abdominal pressure, marked inferior vena cava respiratory translational motion, and the use of compression stockings and patients with inadequate transthoracic window were excluded from the study.

Intermittent hemodialysis sessions

The nephrology team in charge of patient care was responsible for the timing of initiation of dialysis and prescription. Intermittent hemodialysis sessions were performed on the basis of standard clinical guidelines, including AKI with hemodynamic stability, ongoing hypercatabolism, hyperkalemia, severe acidosis, presumed volume overload, and respiratory distress. The indication for intermittent hemodialysis refers to patients without vasopressors or in low dose of vasopressors (norepinephrine dose ≤ 0.3 mg kg−1 min−1) for at least 6 h before initiation of dialysis with mean arterial pressure (MAP) ≥ 65 mmHg. For each patient, clinical, laboratory, and hemodynamic variables were used to inform clinical decision-making of ultrafiltration rate. Intermittent hemodialysis was performed with Fresenius 4008 S (Gambro Hospal, Meyzieu, France), and dialysate concentrate solutions with 1.75 mmol/L calcium concentration. Intradialytic hypotension (IDH) was defined as the occurrence of a MAP below 65 mmHg during the dialysis session [11].

Ultrasound procedures and classifications

Vena cava collapsibility measurement and B line determination were performed by physicians with expertise in cardiac and lung ultrasound for critically ill patients [7, 2022] (see Additional file 5).

Statistical analysis

Statistical analysis was performed using SPSS version 19.0 for Windows (SPSS Inc., Chicago, IL). Data were tested for normality by visual inspection and the use of Kolmogorov-Smirnov test. Continuous variables were expressed as median (interquartile range, IQR) and were compared by a nonparametric Mann-Whitney test. Results are expressed as mean ± SD or median (IQR). Proportions were compared by the χ2 test. Variables were compared between groups of sessions (with hypotension vs without hypotension). The binary classification (“no intradialytic hypotension” vs “intradialytic hypotension”) was used as an outcome variable in a way that “no hypotension” and “hypotension” were coded as 0 and 1, respectively. Quantitative and qualitative variables associated with hypotension with a p value below 0.05 in univariate analysis were selected for inclusion in a multivariable logistic regression model. Logistic regression with both categorical and continuous independent variables was used to build predictive models for the occurrence of hypotension. A one way-ANOVA was used for comparison between groups of patients according to ultrasound profiles. The four “ultrasound profiles” were compared for association with hypotension, dialysis discontinuation, or mortality in 28 days, using χ2 analysis. Statistical significance was assumed at the 5% level.

Results

From January 2016 to March 2018, 248 AKI patients requiring intermittent hemodialysis were considered eligible. Median age was 68, and the age range was 58–76; 149 (60.1%) patients were male; the median Charlson score was 10 (8–12); the median APACHE II score was 15 (12–18); and SOFA score was 8 (6–10).

Intradialytic hypotension: incidence and predictive factors

Patients’ characteristics are shown in Table 1 and hemodialysis sessions’ characteristics in Table 2. IDH was observed in 31.9% (n = 79) of the patients, interruption of dialysis because of IDH occurred in 6.8% (n = 31) of the sessions, and overall 28-day mortality was 20.1%. The presence of sepsis, the use of norepinephrine, a low predialysis MAP, a high predialysis lactate level, the use of mechanical ventilation, and elderly age were factors significantly associated with IDH (Table 1). There was a difference in median ultrafiltration volume (Table 1) between patients with and without IDH: 893 ml (0–1500) in patients with IDH vs 1242 ml (675–2000) in patients without IDH (p = 0.020).
Table 1
Clinical, ultrasound, and biological characteristics of patients
 
All patients
Intradialytic hypotension
p
 
No
Yes
N = 248
169 (68.1%)
79 (31.9%)
Clinical characteristics
 Gender
   
0.684
- Male, n (%)
149 (60.1%)
103 (60.9%)
46 (58.2%)
 
- Female, n (%)
99 (39.9%)
66 (39.1%)
33 (41.8%)
 
 Age (years)
68.0 (58.2–76)
66 (55–76)
70 (64–76)
0.018
 Charlson score
10 (8–12)
10 (8–12)
10 (8–12)
0.116
 APACHE II
15 (12–18)
14 (12–18)
16 (13–18)
0.215
 SOFA
8 (6–100)
8 (6–10)
8 (7–10)
0.057
 Sepsis, n (%)
123 (49.6%)
71 (42%)
52 (65.8%)
< 0.001
 Use of norepinephrine, n (%)
37 (14.9%)
5 (3%)
32 (40.5%)
< 0.001
 Mechanical ventilation, n (%)
34 (13.7%)
14 (8.3%)
20 (25.3%)
< 0.001
Predialytic arterial pressure
 Systolic blood pressure, mmHg
132 (114.2–152)
140 (123–160)
114 (103–135)
< 0.001
 Diastolic blood pressure, mmHg
70 (60.2–80.7)
71 (64–86)
64 (58–73)
< 0.001
 Mean blood pressure, mmHg
89.5 (79.0–105.0)
94 (84–109)
81 (75–90)
< 0.001
Biological characteristics
 Hemoglobin, g/dL
9 (7.6–10.1)
9 (7.4–10.1)
9 (7.8–10.2)
0.839
 Bicarbonate, mEq/L
20(18–23)
20 (18–23)
20 (16–22)
0.321
 Sodium, mEq/L
138 (138–140)
138 (135–141)
139 (134–141)
0.565
 Urea, mg/dL
143 (114.2–194)
143 (110–195)
142 (119–194)
0.659
 Lactate, mmol/L
1.4 (1.1–1.9)
1.3 (1.1–1.7)
1.7 (1.2–2.2)
< 0.001
 Fluid balance, mL
1772 (1540–2320)
1800 (1535–2320)
1750 (1540–2350)
0.762
Ultrasound characteristics
 Pulmonary congestion, n (%)
144 (58.1%)
106 (62.7%)
38 (48.1%)
0.030
 IVC collapsibility, n (%)
74 (29.8%)
14 (8.3%)
60 (75.9%)
< 0.001
APACHE Acute Physiology, Age, Chronic Health Evaluation; SOFA Sequential Organ Failure Assessment score; IVC inferior vena cava; IQR interquartile. Data are expressed as number (percentage) for categorical variables or median (1st quartile–3rd quartile) for continuous variables
Table 2
Dialysis sessions’ characteristics
Dialysis characteristics
All patients
Intradialytic hypotension
p
No
Yes
N = 248
169 (68.1%)
79 (31.9%)
Duration, min
240 (180–240)
240 (180–240)
210 (150–240)
0.140
Ultrafiltration, mL
1000 (200–2000)
1.242.01
893.03
0.020
Blood flow, mL/min
300 (250–300)
  
0.010
- 200
 
24 (14.2%)
24 (30.4%)
 
- 250
 
47 (27.8%)
16 (20.3%)
 
- 300
 
98 (58%)
38 (48.1%)
 
- 350
 
0 (0%)
1 (1.3%)
 
Dialysate flow, mL/min
500 (500–500)
  
0.002
- 300
 
12 (7.1%)
17 (21.5%)
 
- 320
 
0 (0%)
1 (1.3%)
 
- 500
 
157 (92.9%)
61 (77.2%)
 
Temperature, °C
36 (36–36)
36.0 (35.5–36.5)
36.0 (35.5–36.5)
0.416
Sodium, mEq/L
138 (138–140)
138 (138–140)
138 (135–141)
 
Data are expressed as number (percentage) for categorical variables or median (1st quartile–3rd quartile) for continuous variables
Regarding ultrasound findings, pulmonary congestion (as defined by a B line score ≥ 14) was found in 38 (48.1%) patients with IDH and 106 (62.7%) patients without IDH (p = 0.030). Inferior vena cava collapsibility (as defined by a VCDi ≤ 11.5 mm m2) was found in 60 (75.9%) patients with IDH and 14 (8.3%) patients without IDH (p < 0.001).
The predictive multiple logistic regression model of IDH demonstrated that MAP, use of norepinephrine, and inferior vena cava collapsibility were associated with the occurrence of IDH (Table 3). Specifically, pulmonary congestion (a B line score ≥ 14) and higher MAP appeared protective against IDH (Table 3).
Table 3
Multivariate logistic regression analysis for the occurrence of intradialytic hypotension
Variable
Parameter estimated
Standard error
Odds ratio
95% CI
p
Age
0.018
0.015
1.018
0.989–1.049
0.228
Blood flow rate
0.006
0.007
1.006
0.993–1.019
0.379
Dialysate flow rate
− 0.007
0.004
0.993
0.984–1.001
0.096
Ultrafiltration
0.001
0.004
1.000
1.000–1.001
0.136
Mean blood pressure
− 0.039
0.015
0.962
0.934–0.991
0.010
Lactate
− 0.187
0.398
0.829
0.380–1.810
0.638
Use of norepinephrine
2.736
0.679
15.425
4.078–58.353
0.001
Pulmonary congestion
− 1.025
0.462
0.448
0.106–0.888
0.027
Inferior vena cava collapsibility
3.573
0.487
35.635
13.722–92.538
0.001
Mechanical ventilation
− 0.803
0.737
0.359
0.106–1.900
0.276
Sepsis
0.584
0.466
1.793
0.719–4.470
0.210
Constant
1.825
    

Ultrasound profiles

Based on lung ultrasound and VCDi, we could classify patients in four distinct profiles (Fig. 1) (Additional files 1, 2, 3, and 4): (A) 108 patients had pulmonary congestion and hypervolemia, (B) 38 patients did not have pulmonary congestion nor hypervolemia, (C) 36 patients had pulmonary congestion without hypervolemia, and (D) 66 patients had hypervolemia without pulmonary congestion. Baseline characteristics of the patients in the four ultrasound profiles are listed in Table 4. The presence of IDH was different between profiles (p < 0.001). All other variables but age were similar between the four different profiles.
Table 4
Baseline characteristics of patients according to the ultrasound profile
Profile
A, n = 108
B, n = 38
C, n = 36
D, n = 66
p
Hypotension, n (%)
8 (7.4%)
30 (78.9%)
30 (83.3%)
11 (16.7%)
0.001
Gender
    
0.346
 Male, n (%)
67 (62%)
26 (68.4%)
22 (14.8%)
34 (51.4%)
 
 Female, n (%)
41 (41.4%)
12 (31.6%)
14 (38.9%)
32 (48.5%)
 
Age (years)
65.0 ± 15.2
69.9 ± 11.8
66.0 ± 12.4
66.0 ± 18.1
0.016
Charlson score
10.3 ± 2.7
10.6 ± 2.8
10.7 ± 2.6
10.0 ± 2.8
0.113
APACHE II
15.2 ± 3.7
15.6 ± 4.3
15.9 ± 3.3
15.4 ± 5.6
0.470
SOFA
8.2 ± 2.3
8.4 ± 2.6
9.2 ± 2.6
8.4 ± 2.7
0.677
Sepsis, n (%)
59 (54.6%)
17 (44.7%)
15 (41.7%)
32 (48.5%)
0.495
Use of norepinephrine, n (%)
19 (17.6%)
6 (15.8%)
4 (11.1%)
8 (12.1%)
0.694
Mechanical ventilation, n (%)
16 (14.8%)
8 (21.1%)
3 (8.3%)
7 (10.6%)
0.353
Fluid balance (milliliters)
1952.2 ± 702.0
1953.0 ± 673.5
1899.8 ± 667.5
1951.8 ± 592.9
0.469
Mortality 28 days, n (%)
19 (17.6%)
6 (15.8%)
5 (13.9%)
20 (30.3%)
0.112
Dialysis data
 Duration, min
212.4 ± 47.5
202.6 ± 53.1
195.14 ± 81.1
212.7 ± 40.7
0.958
 Ultrafiltration, mL/min
1197.2 ± 836.6
1072.4 ± 923.3
813.9 ± 818
1228.8 ± 40.7
0.428
 Blood flow rate, mL/min
273.15 ± 35.80
248.7 ± 48.6
262.5 ± 42.0
274.24 ± 35.3
0.420
 Dialysate flow rate, mL/min
485.18 ± 56.62
447.9 ± 88.4
455.5 ± 84.3
487.9 ± 48.1
0.628
 Sodium, mEq/L
138.66 ± 1.28
138.6 ± 0.9
138.8 ± 1.5
138.8 ± 1.9
0.841
Systemic data
 Temperature
36.06 ± 0.25
36.0 ± 0.3
36.0 ± 0.3
36.0 ± 26.1
0.326
 Systolic blood pressure, mmHg
139.1 ± 28.5
126.0 ± 0.3
123.0 ± 22.5
144.4 ± 26.1
0.855
 Diastolic blood pressure, mmHg
72.8 ± 15.8
68.6 ± 16.9
67.2 ± 12.7
73.9 ± 16.8
0.831
 Mean blood pressure, mmHg
94.9 ± 18.4
87.8 ± 18.3
85.8 ± 13.6
97.4 ± 17.5
0.793
Blood test data
 Hemoglobin, /dL
9.1 ± 2.2
9.2 ± 2.2
8.6 ± 2.2
8.6 ± 2.2
0.262
 Bicarbonate, mEq/L
19.7 ± 3.8
18.8 ± 3.8
20.1 ± 5.2
20.1 ± 5.2
0.767
 Sodium, mEq/L
138.2 ± 4.5
138.9 ± 8.5
137.4 ± 5.4
137.0 ± 6.6
0.396
 Urea, mg/dL
157.6 ± 59.3
159.9 ± 50.3
157.5 ± 47.8
150.1 ± 61.7
0.802
 Lactate, mmol/L
1.5 ± 0.6
1.8 ± 0.85
2.0 ± 1.1
1.5 ± 0.5
0.242
SOFA Sequential Organ Failure Assessment, APACHE Acute Physiology and Chronic Health Evaluation. Data are expressed as mean ± standard deviation

Clinical outcomes vs ultrasound profiles

Table 5 shows the risk for IDH, early interruption of intermittent hemodialysis, and 28-day mortality. Patients in profile D appeared to have a lower risk for all outcomes. There was an increased risk of IDH, dialysis discontinuation, and 28-day mortality in patients with profiles B and C.
Table 5
Ultrasound profiles vs outcomes
Profile
Parameter estimated
Standard error
Odds ratio
95% CI
 
p
Hypotension
 A
− 2.530
0.404
0.08
0.036
0.176
0.001
 B
2.511
0.430
12.321
5.304
28.624
0.001
 C
2.811
0.476
16.633
6.544
42.277
0.001
 D
− 1.093
0.364
0.335
0.164
0.684
0.003
Dialysis discontinuation
 A
− 2.608
1.039
0.074
0.010
0.565
0.012
 B
4.516
0.526
4.516
1.601
12.743
0.004
 C
1.863
0.526
6.444
2.298
18.071
0.001
 D
− 1.835
1.041
0.160
0.021
1.228
0.780
Mortality 28 days
 A
− 1.072
0.360
0.342
0.169
0.694
0.003
 B
0.580
0.399
1.786
0.817
3.907
0.146
 C
1.284
0.385
3.612
1.697
7.688
0.001
 D
− 0.172
0.368
0.842
0.410
1.731
0.640

Discussion

In this study, we describe four clinical profiles based on ultrasound findings and their relation to IDH, interruption of dialysis, and overall mortality at 28 days. Patients with pulmonary congestion and hypervolemia (profile A) had a lower risk of IDH. In contrast, patients without pulmonary congestion and hypervolemia had the highest incidence of IDH. Sepsis, the use of norepinephrine, a low predialysis MAP, lactate level, and mechanical ventilation were significantly associated with IDH.
The pathogenesis of IDH includes the dialysis process itself and critically ill patient-related factors such as sepsis and sedation. Cardiac output and peripheral vasomotor tone are the main determinants of arterial pressure. In critically ill patients, dialysis hypotension is a result of the imbalance of these two variables [23]. Sepsis is the main etiology of AKI and causes a decrease in the peripheral vasomotor tone, induced by the release of vasodilating inflammatory mediators [24, 25]. During the ultrafiltration process, plasma volume decreases leading to an increase in protein level [26]. The resulting increase in oncotic pressure induces a water shift from interstitial and intracellular compartments toward intravascular compartment, which limits ultrafiltration-induced hypovolemia [27]. When ultrafiltration rate surpasses refilling rate, reduction in preload induces a fall in stroke volume that predisposes to hemodynamic instability [23, 27]. Normally, two physiological mechanisms are activated to maintain cardiac output and arterial pressure despite the reduction of stroke volume: an increase in heart rate and an increase in systemic vascular resistance. The dialysis process, however, interferes with this compensatory process [28]. Several mechanisms have been incriminated [27]: diffusion-induced changes in osmolality impairing baroreceptor activation, dialysis of plasma norepinephrine, calcium dialysate concentrations, and dialysate temperature. The hemodynamic impact of ultrafiltration is higher in critically ill patients with preload dependence and altered vasomotor tone [29].
Application of ultrasound has improved the care of critically ill patients with kidney diseases by providing an accurate estimation of volume status [14, 15] and pulmonary congestion [22]. It is also an accurate monitoring of treatment efficiency: the rate of disappearance of B lines following hemodialysis correlates with ultrafiltration and dry weight [5, 8]. Ultrasound determination of IVC expiratory diameter and collapsibility combined with clinical parameters have been used to monitor volume unloading during hemodialysis [2932]. In the present study, critically ill patients treated by norepinephrine without hypervolemia were at high risk of IDH. We identified two profiles based on lung and vascular ultrasound able to predict the risk of IDH and guide the type of dialysis session. Critically ill patients with VCDi ≤ 11.5 mm m−2, an ultrasound value ruling out hypervolemia, were at risk of IDH in the presence or absence of lung congestion. At the opposite, hypervolemia defined as a VCDi ≥ 11.5 mm m−2 was protective against IDH in the presence or absence of lung congestion.
Before starting intermittent hemodialysis, the identification of patients with cardiopulmonary profiles increasing the risk of intradialytic hypotension should incite the clinician to select an alternative dialysis technique. Implementation of practice guidelines for intermittent hemodialysis can lessen hemodynamic instability [2]. Continuous renal replacement therapies (CRRT) provide hemodynamic stability, but the continuous session lasting 24–96 h requires expertise, anticoagulation, and alarm vigilance [33]. Extended daily dialysis is associated with similar outcomes to CRRT; however, further high-quality randomized controlled trials are desirable [34]. A technique of dialysis personalized to the risk of intradialytic hypotension is of critical importance, since intradialytic hypotension can increase mortality [35]. Recently, it has been shown that a high ultrafiltration rate (> 25 ml/kg/day) over the period of RRT significantly reduces the risk of 1-year mortality in 1075 patients with AKI and fluid overload > 5% of body weight [36]. Interestingly, MAP was lower for duration of RRT and cumulative norepinephrine dose higher in patients treated with low or moderate ultrafiltration rate, suggesting that IDH increased the mortality risk. However, it was impossible to conclude whether tolerating intensive ultrafiltration is simply a marker of recovery or a mediator [37]. Our results are similar: it is likely that the increased 28-day mortality observed in the 79 critically ill patients who experienced intradialytic hypotension was partly due to the hypotensive episodes, but the finding of increased mortality in patients with dialytic hypotension does not necessarily mean that hypotension causes mortality.
Our study has some limitations. It is a single-center study, and our findings have to be reproduced and our hypothesis tested in multicenter randomized controlled trials. We have only performed ultrasound studies just before hemodialysis initiation. The vena cava collapsibility was assessed either in patients with or without mechanical ventilation. The patients on mechanical ventilation, however, were lightly sedated and partly spontaneous breathing.

Conclusion

In critically ill patients with objective indications of emergent initiation of hemodialysis, the absence of hypervolemia with or without pulmonary congestion as assessed by vena cava and lung ultrasound predisposes to intradialytic hypotension. Further studies should be considered to validate these results and personalize the techniques of dialysis according to the risk of intradialytic hypotension.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s13054-019-2668-2.

Acknowledgements

The authors are grateful to the Nephrology Team of the Hospital Português (Dr Andrea Pedroza, Dr. Fabio Dutra, Dr. Margarida Dutra, Dr. Luis Conceição, Dra Eva Miranda, Dr. Evandro Mendonça, and Dra. Fernanda Oliveira Coelho, Carolina Sá Nascimento).
The study was approved by the Ethical Committee from Centro de Estudos Egaz Muniz (CAAE: 89428318.000005029). Written informed consent was waived for this observational and non-interventional study.
All authors reviewed the manuscript and consented to its publication.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrol. 2016;17:109.CrossRef Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrol. 2016;17:109.CrossRef
2.
Zurück zum Zitat Schortgen F, Soubrier N, Delclaux C, Thuong M, Girou E, Brun-Buisson C, et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am J Respir Crit Care Med. 2000;162:197–202.CrossRef Schortgen F, Soubrier N, Delclaux C, Thuong M, Girou E, Brun-Buisson C, et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am J Respir Crit Care Med. 2000;162:197–202.CrossRef
3.
Zurück zum Zitat Doshi M, Murray PT. Approach to intradialytic hypotension in intensive care unit patients with acute renal failure. Artif Organs. 2003;27:772–80.CrossRef Doshi M, Murray PT. Approach to intradialytic hypotension in intensive care unit patients with acute renal failure. Artif Organs. 2003;27:772–80.CrossRef
4.
Zurück zum Zitat Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, et al. The agreement between auscultation and lung ultrasound in hemodialysis patients: the LUST study. Clin J Am Soc Nephrol CJASN. 2016;11:2005–11.CrossRef Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, et al. The agreement between auscultation and lung ultrasound in hemodialysis patients: the LUST study. Clin J Am Soc Nephrol CJASN. 2016;11:2005–11.CrossRef
5.
Zurück zum Zitat Ross DW, Abbasi MM, Jhaveri KD, Sachdeva M, Miller I, Barnett R, et al. Lung ultrasonography in end-stage renal disease: moving from evidence to practice-a narrative review. Clin Kidney J. 2018;11:172–8.CrossRef Ross DW, Abbasi MM, Jhaveri KD, Sachdeva M, Miller I, Barnett R, et al. Lung ultrasonography in end-stage renal disease: moving from evidence to practice-a narrative review. Clin Kidney J. 2018;11:172–8.CrossRef
6.
Zurück zum Zitat Zoccali C, Torino C, Tripepi R, Tripepi G, D’Arrigo G, Postorino M, et al. Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol JASN. 2013;24:639–46.CrossRef Zoccali C, Torino C, Tripepi R, Tripepi G, D’Arrigo G, Postorino M, et al. Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol JASN. 2013;24:639–46.CrossRef
7.
Zurück zum Zitat Mallamaci F, Benedetto FA, Tripepi R, Rastelli S, Castellino P, Tripepi G, et al. Detection of pulmonary congestion by chest ultrasound in dialysis patients. JACC Cardiovasc Imaging. 2010;3:586–94.CrossRef Mallamaci F, Benedetto FA, Tripepi R, Rastelli S, Castellino P, Tripepi G, et al. Detection of pulmonary congestion by chest ultrasound in dialysis patients. JACC Cardiovasc Imaging. 2010;3:586–94.CrossRef
8.
Zurück zum Zitat Noble VE, Murray AF, Capp R, Sylvia-Reardon MH, Steele DJR, Liteplo A. Ultrasound assessment for extravascular lung water in patients undergoing hemodialysis. Time course for resolution. Chest. 2009;135:1433–9.CrossRef Noble VE, Murray AF, Capp R, Sylvia-Reardon MH, Steele DJR, Liteplo A. Ultrasound assessment for extravascular lung water in patients undergoing hemodialysis. Time course for resolution. Chest. 2009;135:1433–9.CrossRef
9.
Zurück zum Zitat Douvris A, Zeid K, Hiremath S, Bagshaw SM, Wald R, Beaubien-Souligny W, et al. Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review. Intensive Care Med. 2019;45(10):1333–46.CrossRef Douvris A, Zeid K, Hiremath S, Bagshaw SM, Wald R, Beaubien-Souligny W, et al. Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review. Intensive Care Med. 2019;45(10):1333–46.CrossRef
10.
Zurück zum Zitat Monnet X, Cipriani F, Camous L, Sentenac P, Dres M, Krastinova E, et al. The passive leg raising test to guide fluid removal in critically ill patients. Ann Intensive Care. 2016;6:46.CrossRef Monnet X, Cipriani F, Camous L, Sentenac P, Dres M, Krastinova E, et al. The passive leg raising test to guide fluid removal in critically ill patients. Ann Intensive Care. 2016;6:46.CrossRef
11.
Zurück zum Zitat Bitker L, Bayle F, Yonis H, Gobert F, Leray V, Taponnier R, et al. Prevalence and risk factors of hypotension associated with preload-dependence during intermittent hemodialysis in critically ill patients. Crit Care. 2016;20:44.CrossRef Bitker L, Bayle F, Yonis H, Gobert F, Leray V, Taponnier R, et al. Prevalence and risk factors of hypotension associated with preload-dependence during intermittent hemodialysis in critically ill patients. Crit Care. 2016;20:44.CrossRef
12.
Zurück zum Zitat O’Connor ME, Jones SL, Glassford NJ, Bellomo R, Prowle JR. Defining fluid removal in the intensive care unit: a national and international survey of critical care practice. J Intensive Care Soc. 2017;18:282–8.CrossRef O’Connor ME, Jones SL, Glassford NJ, Bellomo R, Prowle JR. Defining fluid removal in the intensive care unit: a national and international survey of critical care practice. J Intensive Care Soc. 2017;18:282–8.CrossRef
13.
Zurück zum Zitat van der Sande FM, Dekker MJ, Leunissen KML, Kooman JP. Novel insights into the pathogenesis and prevention of intradialytic hypotension. Blood Purif. 2018;45:230–5.CrossRef van der Sande FM, Dekker MJ, Leunissen KML, Kooman JP. Novel insights into the pathogenesis and prevention of intradialytic hypotension. Blood Purif. 2018;45:230–5.CrossRef
14.
Zurück zum Zitat Kalantari K, Chang JN, Ronco C, Rosner MH. Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int. 2013;83:1017–28.CrossRef Kalantari K, Chang JN, Ronco C, Rosner MH. Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int. 2013;83:1017–28.CrossRef
15.
Zurück zum Zitat Niyyar VD, O’Neill WC. Point-of-care ultrasound in the practice of nephrology. Kidney Int. 2018;93:1052–9.CrossRef Niyyar VD, O’Neill WC. Point-of-care ultrasound in the practice of nephrology. Kidney Int. 2018;93:1052–9.CrossRef
16.
Zurück zum Zitat Krause I, Birk E, Davidovits M, Cleper R, Blieden L, Pinhas L, et al. Inferior vena cava diameter: a useful method for estimation of fluid status in children on haemodialysis. Nephrol Dial Transplant. 2001;16:1203–6.CrossRef Krause I, Birk E, Davidovits M, Cleper R, Blieden L, Pinhas L, et al. Inferior vena cava diameter: a useful method for estimation of fluid status in children on haemodialysis. Nephrol Dial Transplant. 2001;16:1203–6.CrossRef
17.
Zurück zum Zitat Kaptein MJ, Kaptein JS, Oo Z, Kaptein EM. Relationship of inferior vena cava collapsibility to ultrafiltration volume achieved in critically ill hemodialysis patients. Int J Nephrol Renov Dis. 2018;11:195–209.CrossRef Kaptein MJ, Kaptein JS, Oo Z, Kaptein EM. Relationship of inferior vena cava collapsibility to ultrafiltration volume achieved in critically ill hemodialysis patients. Int J Nephrol Renov Dis. 2018;11:195–209.CrossRef
18.
Zurück zum Zitat Clerico A, Vittorini S, Passino C. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance. Clin Chem Lab Med. 2011;49:1949–54.CrossRef Clerico A, Vittorini S, Passino C. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance. Clin Chem Lab Med. 2011;49:1949–54.CrossRef
19.
Zurück zum Zitat Samoni S, Vigo V, Reséndiz LIB, Villa G, De Rosa S, Nalesso F, et al. Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording. Crit Care. 2016;20:95.CrossRef Samoni S, Vigo V, Reséndiz LIB, Villa G, De Rosa S, Nalesso F, et al. Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording. Crit Care. 2016;20:95.CrossRef
20.
Zurück zum Zitat Cheriex EC, Leunissen KM, Janssen JH, Mooy JM, van Hooff JP. Echography of the inferior vena cava is a simple and reliable tool for estimation of “dry weight” in haemodialysis patients. Nephrol Dial Transplant. 1989;4:563–8.PubMed Cheriex EC, Leunissen KM, Janssen JH, Mooy JM, van Hooff JP. Echography of the inferior vena cava is a simple and reliable tool for estimation of “dry weight” in haemodialysis patients. Nephrol Dial Transplant. 1989;4:563–8.PubMed
21.
Zurück zum Zitat Muniz Pazeli J, Fagundes Vidigal D, Cestari Grossi T, Silva Fernandes NM, Colugnati F, Baumgratz de Paula R, et al. Can nephrologists use ultrasound to evaluate the inferior vena cava? A cross-sectional study of the agreement between a nephrologist and a cardiologist. Nephron Extra. 2014;4:82–8.CrossRef Muniz Pazeli J, Fagundes Vidigal D, Cestari Grossi T, Silva Fernandes NM, Colugnati F, Baumgratz de Paula R, et al. Can nephrologists use ultrasound to evaluate the inferior vena cava? A cross-sectional study of the agreement between a nephrologist and a cardiologist. Nephron Extra. 2014;4:82–8.CrossRef
22.
Zurück zum Zitat Gargani L. Lung ultrasound: a new tool for the cardiologist. Cardiovasc Ultrasound. 2011;9:6.CrossRef Gargani L. Lung ultrasound: a new tool for the cardiologist. Cardiovasc Ultrasound. 2011;9:6.CrossRef
23.
Zurück zum Zitat Schortgen F. Hypotension during intermittent hemodialysis: new insights into an old problem. Intensive Care Med. 2003;29:1645–9.CrossRef Schortgen F. Hypotension during intermittent hemodialysis: new insights into an old problem. Intensive Care Med. 2003;29:1645–9.CrossRef
24.
Zurück zum Zitat Monge García MI, Guijo González P, Gracia Romero M, Gil Cano A, Oscier C, Rhodes A, et al. Effects of fluid administration on arterial load in septic shock patients. Intensive Care Med. 2015;41:1247–55.CrossRef Monge García MI, Guijo González P, Gracia Romero M, Gil Cano A, Oscier C, Rhodes A, et al. Effects of fluid administration on arterial load in septic shock patients. Intensive Care Med. 2015;41:1247–55.CrossRef
25.
Zurück zum Zitat Ait-Oufella H, Maury E, Lehoux S, Guidet B, Offenstadt G. The endothelium: physiological functions and role in microcirculatory failure during severe sepsis. Intensive Care Med. 2010;36:1286–98.CrossRef Ait-Oufella H, Maury E, Lehoux S, Guidet B, Offenstadt G. The endothelium: physiological functions and role in microcirculatory failure during severe sepsis. Intensive Care Med. 2010;36:1286–98.CrossRef
26.
Zurück zum Zitat Pietribiasi M, Katzarski K, Galach M, Stachowska-Piętka J, Schneditz D, Lindholm B, et al. Kinetics of plasma refilling during hemodialysis sessions with different initial fluid status. ASAIO J Am Soc Artif Intern Organs. 2015;61:350–6.CrossRef Pietribiasi M, Katzarski K, Galach M, Stachowska-Piętka J, Schneditz D, Lindholm B, et al. Kinetics of plasma refilling during hemodialysis sessions with different initial fluid status. ASAIO J Am Soc Artif Intern Organs. 2015;61:350–6.CrossRef
27.
Zurück zum Zitat Rouby JJ, Rottembourg J, Durande JP, Basset JY, Legrain M. Importance of the plasma refilling rate in the genesis of hypovolaemic hypotension during regular dialysis and controlled sequential ultrafiltration-haemodialysis. Proc Eur Dial Transpl. 1978;15:239–44. Rouby JJ, Rottembourg J, Durande JP, Basset JY, Legrain M. Importance of the plasma refilling rate in the genesis of hypovolaemic hypotension during regular dialysis and controlled sequential ultrafiltration-haemodialysis. Proc Eur Dial Transpl. 1978;15:239–44.
28.
Zurück zum Zitat Rouby JJ, Rottembourg J, Durande J-P, Basset J-Y, Degoulet P, Glaser P, et al. Hemodynamic changes induced by regular hemodialysis and sequential ultrafiltration hemodialysis: a comparative study. Kidney Int. 1980;17:801–10.CrossRef Rouby JJ, Rottembourg J, Durande J-P, Basset J-Y, Degoulet P, Glaser P, et al. Hemodynamic changes induced by regular hemodialysis and sequential ultrafiltration hemodialysis: a comparative study. Kidney Int. 1980;17:801–10.CrossRef
29.
Zurück zum Zitat Ronco C, Ricci Z. Renal replacement therapies: physiological review. Intensive Care Med. 2008;34:2139–46.CrossRef Ronco C, Ricci Z. Renal replacement therapies: physiological review. Intensive Care Med. 2008;34:2139–46.CrossRef
30.
Zurück zum Zitat Tetsuka T, Ando Y, Ono S, Asano Y. Change in inferior vena caval diameter detected by ultrasonography during and after hemodialysis. ASAIO J Am Soc Artif Intern Organs. 1995;41:105–10. Tetsuka T, Ando Y, Ono S, Asano Y. Change in inferior vena caval diameter detected by ultrasonography during and after hemodialysis. ASAIO J Am Soc Artif Intern Organs. 1995;41:105–10.
31.
Zurück zum Zitat Brennan JM, Ronan A, Goonewardena S, Blair JEA, Hammes M, Shah D, et al. Handcarried ultrasound measurement of the inferior vena cava for assessment of intravascular volume status in the outpatient hemodialysis clinic. Clin J Am Soc Nephrol CJASN. 2006;1:749–53.CrossRef Brennan JM, Ronan A, Goonewardena S, Blair JEA, Hammes M, Shah D, et al. Handcarried ultrasound measurement of the inferior vena cava for assessment of intravascular volume status in the outpatient hemodialysis clinic. Clin J Am Soc Nephrol CJASN. 2006;1:749–53.CrossRef
32.
Zurück zum Zitat Guiotto G, Masarone M, Paladino F, Ruggiero E, Scott S, Verde S, et al. Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot study. Intensive Care Med. 2010;36:692–6.CrossRef Guiotto G, Masarone M, Paladino F, Ruggiero E, Scott S, Verde S, et al. Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot study. Intensive Care Med. 2010;36:692–6.CrossRef
33.
Zurück zum Zitat Wehle B, Asaba H, Castenfors J, Fürst P, Gunnarsson B, Shaldon S, et al. Hemodynamic changes during sequential ultrafiltration and dialysis. Kidney Int. 1979;15:411–8.CrossRef Wehle B, Asaba H, Castenfors J, Fürst P, Gunnarsson B, Shaldon S, et al. Hemodynamic changes during sequential ultrafiltration and dialysis. Kidney Int. 1979;15:411–8.CrossRef
34.
Zurück zum Zitat Villa G, Neri M, Bellomo R, Cerda J, De Gaudio AR, De Rosa S, et al. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications. Crit Care. 2016;20:283.CrossRef Villa G, Neri M, Bellomo R, Cerda J, De Gaudio AR, De Rosa S, et al. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications. Crit Care. 2016;20:283.CrossRef
35.
Zurück zum Zitat Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM. Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol JASN. 2015;26:724–34.CrossRef Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM. Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol JASN. 2015;26:724–34.CrossRef
36.
Zurück zum Zitat Murugan R, Kerti SJ, Chang C-CH, Gallagher M, Clermont G, Palevsky PM, et al. Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open. 2019;2:e195418.CrossRef Murugan R, Kerti SJ, Chang C-CH, Gallagher M, Clermont G, Palevsky PM, et al. Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open. 2019;2:e195418.CrossRef
37.
Zurück zum Zitat Murugan R, Balakumar V, Kerti SJ, Priyanka P, Chang C-CH, Clermont G, et al. Net ultrafiltration intensity and mortality in critically ill patients with fluid overload. Crit Care. 2018;22:223.CrossRef Murugan R, Balakumar V, Kerti SJ, Priyanka P, Chang C-CH, Clermont G, et al. Net ultrafiltration intensity and mortality in critically ill patients with fluid overload. Crit Care. 2018;22:223.CrossRef
Metadaten
Titel
Ultrasound-based clinical profiles for predicting the risk of intradialytic hypotension in critically ill patients on intermittent dialysis: a prospective observational study
verfasst von
Rogerio da Hora Passos
Juliana Caldas
Joao Gabriel Rosa Ramos
Erica Batista dos Santos Galvão de Melo
Michel Por Deus Ribeiro
Maria Fernanda Coelho Alves
Paulo Benigno Pena Batista
Octavio Henrique Coelho Messeder
Augusto Manoel de Carvalho de Farias
Etienne Macedo
Jean Jacques Rouby
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 1/2019
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-019-2668-2

Weitere Artikel der Ausgabe 1/2019

Critical Care 1/2019 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.